Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss

GLP-1/Glucagon Coagonism Restores Leptin Responsiveness in Obese Mice Chronically Maintained on an Obesogenic Diet

(2013) C. Clemmensen et al.   DIABETES

Dose response of continuous subcutaneous infusion of recombinant glucagon-like peptide-1 in combination with metformin and sulphonylurea over 12 weeks in patients with type 2 diabetes mellitus

(2013) S. S. Torekov et al.   DIABETES OBESITY & METABOLISM

Co-localisation and secretion of glucagon-like peptide 1 and peptide YY from primary cultured human L cells

(2013) A. M. Habib et al.   DIABETOLOGIA

Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults

(2013) M E J Lean et al.   INTERNATIONAL JOURNAL OF OBESITY

Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults

(2013) J van Can et al.   INTERNATIONAL JOURNAL OF OBESITY

Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study

(2013) T A Wadden et al.   INTERNATIONAL JOURNAL OF OBESITY

Leptin reverses declines in satiation in weight-reduced obese humans

(2012) Harry R Kissileff et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Lower leptin levels are associated with higher risk of weight gain over 2 years in healthy young adults

(2012) Catherine Allard et al.   Applied Physiology Nutrition and Metabolism

Liraglutide: short-lived effect on gastric emptying-long lasting effects on body weight

(2012) J. Jelsing et al.   DIABETES OBESITY & METABOLISM

Restoration of leptin responsiveness in diet-induced obese mice using an optimized leptin analog in combination with exendin-4 or FGF21

(2012) Timo D. Müller et al.   JOURNAL OF PEPTIDE SCIENCE

Cardiometabolic Risk After Weight Loss and Subsequent Weight Regain in Overweight and Obese Postmenopausal Women

(2012) D. P. Beavers et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

Novel Regulatory Mechanisms for Generation of the Soluble Leptin Receptor: Implications for Leptin Action

(2012) Michael Schaab et al.   PLoS One

Rapid Tachyphylaxis of the Glucagon-Like Peptide 1-Induced Deceleration of Gastric Emptying in Humans

(2011) M. A. Nauck et al.   DIABETES

Dose response of subcutaneous GLP-1 infusion in patients with type 2 diabetes

(2011) S. S. Torekov et al.   DIABETES OBESITY & METABOLISM

Effects of exenatide twice daily versus sitagliptin on 24-h glucose, glucoregulatory and hormonal measures: a randomized, double-blind, crossover study

(2011) J. K. Berg et al.   DIABETES OBESITY & METABOLISM

Incretin Hormone and Insulin Responses to OralVersusIntravenous Lipid Administration in Humans

(2011) Ola Lindgren et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Long-Term Persistence of Hormonal Adaptations to Weight Loss

(2011) Priya Sumithran et al.   NEW ENGLAND JOURNAL OF MEDICINE

Obesity - an indication for GLP-1 treatment? Obesity pathophysiology and GLP-1 treatment potential

(2011) S. S. Torekov et al.   Obesity Reviews

Leptin, Soluble Leptin Receptors, Free Leptin Index, and Their Relationship with Insulin Resistance and BMI: High Normal BMI is the Threshold for Serum Leptin Increase in Humans

(2010) M. Owecki et al.   HORMONE AND METABOLIC RESEARCH

Adaptive thermogenesis in humans

(2010) M Rosenbaum et al.   INTERNATIONAL JOURNAL OF OBESITY

Leptin Replacement Prevents Weight Loss-Induced Metabolic Adaptation in Congenital Leptin-Deficient Patients

(2010) Jose E. Galgani et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Comparing two low-energy diets for the treatment of knee osteoarthritis symptoms in obese patients: a pragmatic randomized clinical trial

(2010) B.F. Riecke et al.   OSTEOARTHRITIS AND CARTILAGE

The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice

(2009) J. Hsieh et al.   DIABETOLOGIA

Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study

(2009) Arne Astrup et al.   LANCET

All-trans Retinoic Acid Inhibits Type 1 Diabetes by T Regulatory (Treg)-Dependent Suppression of Interferon- -Producing T-cells Without Affecting Th17 Cells

(2008) Y.-H. Van et al.   DIABETES